EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 22 / No 6-7 (Juin-Juillet 2006) Med Sci (Paris), 22 6-7 (2006) 645-650 References
Free Access
Issue
Med Sci (Paris)
Volume 22, Number 6-7, Juin-Juillet 2006
Page(s) 645 - 650
Section M/S revues
DOI https://doi.org/10.1051/medsci/20062267645
Published online 15 June 2006
  1. Canale VC, Smith CH. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr 1967; 70 : 891–9. [Google Scholar]
  2. Rieux-Laucat F, Fischer A, Deist FL. Cell-death signaling and human disease. Curr Opin Immunol 2003; 15 : 325–31. [Google Scholar]
  3. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes : genetic defects of apoptosis pathways. Cell Death Differ 2003; 10 : 124–33. [Google Scholar]
  4. Lavrik I, Golks A, Krammer PH. Death receptor signaling. J Cell Sci 2005; 118 : 265–7. [Google Scholar]
  5. Peter ME, Krammer PH. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ 2003; 10 :26–35. [Google Scholar]
  6. Nagata S, Suda T. Fas and Fas ligand : lpr and gld mutations. Immunol Today 1995; 16 : 39–43. [Google Scholar]
  7. Pestano GA, Zhou Y, Trimble LA, et al. Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. Science 1999; 284 : 1187–91. [Google Scholar]
  8. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268 : 1347–9. [Google Scholar]
  9. Benkerrou M, Le Deist F, de Villartay J, et al. Correction of fas (CD95) deficiency by haploidentical bone marrow transplantation. Eur J Immunol 1997; 27 : 2043–7. [Google Scholar]
  10. Rieux-Laucat F, Blachere S, Danielan S, et al. Lymphoproliferative syndrome with autoimmunity : a possible genetic basis for dominant expression of the clinical manifestations. Blood 1999; 94 : 2575–82. [Google Scholar]
  11. Vaishnaw AK, Orlinick JR, Chu JL, et al. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. J Clin Invest 1999; 103 : 355–63. [Google Scholar]
  12. Bleesing JJ, Brown MR, Straus SE, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001; 98 : 2466–73. [Google Scholar]
  13. Drappa J, Vaishnaw AK, Sullivan KE, et al. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996; 335 : 1643–9. [Google Scholar]
  14. Jackson CE, Fischer RE, Hsu AP, et al. Autoimmune lymphoproliferative syndrome with defective Fas : genotype influences penetrance. Am J Hum Genet 1999; 64 : 1002–14. [Google Scholar]
  15. Morel L, Tian XH, Croker BP, Wakeland EK. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 1999; 11 : 131–9. [Google Scholar]
  16. Wang J, Zheng L, Lobito A, et al. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999; 98 : 47–58. [Google Scholar]
  17. Gronbaek K, Dalby T, Zeuthen J, et al. The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. Blood 2000; 95 : 2184–5. [Google Scholar]
  18. Chun HJ, Zheng L, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419 : 395–9. [Google Scholar]
  19. Su H, Bidere N, Zheng L, et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005; 307 : 1465–8. [Google Scholar]
  20. Salmena L, Lemmers B, Hakem A, et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17 : 883–95. [Google Scholar]
  21. Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004; 351 : 1409–18. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.